[Hepatitis during treatment with tamoxifen. Effects on the kinetics of epirubicin].
Bressollette
L
L
Swirsky
H
H
Kernaleguen
D
D
Carlhant
D
D
Fauquert
P
P
Le Bot
M A
MA
Baccino
E
E
Riche
C
C
D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D001943:Breast Neoplasms; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D015251:Epirubicin / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D008875:Middle Aged; D013629:Tamoxifen / Q000009:adverse effects*
D013629:Tamoxifen; D015251:Epirubicin
Hépatite au cours d'un traitement au tamoxifène. Retentissements sur la cinétique de l'épirubicine.